2017, Number 4

October-Diciembre, 2017; Volume 34: Number 4
Biotecnol Apl 2017; 34 (4)

Research

Using Montanide^™ ISA 50 V2 as adjuvant for the formulation of the anti-tick Gavac® vaccine

Genetic stability of the Primary Cell Bank expressing the recombinant antigen MY32/Ls of Sea lice

Technique

Methods for determining the biological activity of nematicidal products

Focus

Comparison of economic indicators of the sucrose acid inversion or by enzymatic hydrolysis

Report

Biotecnología Aplicada

2017, Number 4

Contents

Research

Using Montanide^™ ISA 50 V2 as adjuvant for the formulation of the anti-tick Gavac® vaccine

Genetic stability of the Primary Cell Bank expressing the recombinant antigen MY32/Ls of Sea lice

Technique

Methods for determining the biological activity of nematicidal products

Focus

Comparison of economic indicators of the sucrose acid inversion or by enzymatic hydrolysis

Report

First International Conference Bioprocess Cuba 2017

2017, Number 4

Contents

Research

Using Montanide™ ISA 50 V2 as adjuvant for the formulation of the anti-tick Gavac® vaccine

Genetic stability of the Primary Cell Bank expressing the recombinant antigen MY32/Ls of Sea lice

Technique

Methods for determining the biological activity of nematicidal products

Focus

Comparison of economic indicators of the sucrose acid inversion or by enzymatic hydrolysis

Report

First International Conference Bioprocess Cuba 2017

Using Montanide^™ ISA 50 V2 as adjuvant for the formulation of the anti-tick Gavac® vaccine